And before you say it, yes I'm talking down GERN on the internet because that will protect my INCY position!
Seriously though, there is nothing controversial in what jq and I are saying. The data are written in the abstract and the response criteria are clear. You'll note that in the Sanofi JAK inhibitor abstract from that group, they note the spleen responses.
And seriously your hematologist should know about Jakafi's survival data. That ain't no joke.
Market Data 
Markets 
AI
